19.13 USD
▲+0.46+0.63%
盘后 18.92 -0.47%
2026-08-03
市值
$3.70B
市盈率
—
EPS
-1.38
股息率
—
52 周区间
16.24 – 39.16
成交量
2.57M
Beta
0.34
目标价
52.10
52W 低 16.2452W 高 39.16
价格走势
公司简介
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including acute lym...